Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives

C. Genova, G. Rossi, M. Tagliamento, E. Rijavec, F. Biello, L. Cerbone, L. Zullo, F. Grossi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)367-383
Number of pages17
JournalExpert Review of Respiratory Medicine
Issue number4
Publication statusPublished - 2020


  • Non-small cell lung cancer
  • oncogenic drivers
  • targeted therapy
  • anaplastic lymphoma kinase
  • anaplastic lymphoma kinase inhibitor
  • B Raf kinase
  • B Raf kinase inhibitor
  • epidermal growth factor receptor 2
  • epidermal growth factor receptor kinase inhibitor
  • neurotrophic tyrosine kinase receptor
  • oncoprotein
  • protein Ret
  • protein tyrosine kinase
  • protein tyrosine kinase inhibitor
  • ROS proto oncogene 1
  • scatter factor receptor
  • unclassified drug
  • advanced cancer
  • carcinogenesis
  • drug targeting
  • human
  • molecularly targeted therapy
  • non small cell lung cancer
  • oncogene
  • Review

Cite this